Yan, Xiang
Feng, Chen
Lou, Ying
Zhou, Zhiguang
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and Safety of LY2963016 Insulin Glargine in Chinese Patients with Type 1 Diabetes Previously Treated with Insulin Glargine (Lantus®): a Post Hoc Analysis of a Randomized, Open-Label, Phase 3 Trial
https://doi.org/10.1007/s13300-022-01262-8
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 17 February 2022
Accepted: 25 March 2022
First Online: 26 April 2022